Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology

5-aminolevulinic acid (ALA) is a clinically approved prodrug involved in intracellular Heme biosynthesis to produce the natural photosensitizer (PS) Protoporphyrin IX (PpIX). ALA based photodynamic therapy (PDT) has been used to treat various malignant and non-malignant diseases. However, natural AL...

Full description

Bibliographic Details
Main Authors: Liang Lou, Shizhe Zhou, Sijia Tan, Menghua Xiang, Wei Wang, Chuang Yuan, Liqian Gao, Qicai Xiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1137707/full
_version_ 1797894366455398400
author Liang Lou
Shizhe Zhou
Sijia Tan
Menghua Xiang
Wei Wang
Chuang Yuan
Chuang Yuan
Liqian Gao
Qicai Xiao
author_facet Liang Lou
Shizhe Zhou
Sijia Tan
Menghua Xiang
Wei Wang
Chuang Yuan
Chuang Yuan
Liqian Gao
Qicai Xiao
author_sort Liang Lou
collection DOAJ
description 5-aminolevulinic acid (ALA) is a clinically approved prodrug involved in intracellular Heme biosynthesis to produce the natural photosensitizer (PS) Protoporphyrin IX (PpIX). ALA based photodynamic therapy (PDT) has been used to treat various malignant and non-malignant diseases. However, natural ALA has disadvantages such as weak lipophilicity, low stability and poor bioavailability, greatly reducing its clinical performance. The emerging nanotechnology is expected to address these limitations and thus improve the therapeutic outcomes. Herein, we summarized important recent advances in the design of ALA-based prodrugs using nanotechnology to improve the efficacy of PDT. The potential limitations and future perspectives of ALA-based nanomedicines are also briefly presented and discussed.
first_indexed 2024-04-10T07:07:51Z
format Article
id doaj.art-eff54de5c2dc491494e8b2f310b0cbb1
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-10T07:07:51Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-eff54de5c2dc491494e8b2f310b0cbb12023-02-27T05:30:13ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-02-011410.3389/fphar.2023.11377071137707Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnologyLiang Lou0Shizhe Zhou1Sijia Tan2Menghua Xiang3Wei Wang4Chuang Yuan5Chuang Yuan6Liqian Gao7Qicai Xiao8School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University and Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University and Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University and Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University and Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University and Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaXiangya School of Pharmaceutical Sciences, Central South University, Changsha, ChinaDepartment of Hematology, Xiangya Hospital, Central South University, Changsha, ChinaSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University and Shenzhen Campus of Sun Yat-sen University, Shenzhen, ChinaSchool of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University and Shenzhen Campus of Sun Yat-sen University, Shenzhen, China5-aminolevulinic acid (ALA) is a clinically approved prodrug involved in intracellular Heme biosynthesis to produce the natural photosensitizer (PS) Protoporphyrin IX (PpIX). ALA based photodynamic therapy (PDT) has been used to treat various malignant and non-malignant diseases. However, natural ALA has disadvantages such as weak lipophilicity, low stability and poor bioavailability, greatly reducing its clinical performance. The emerging nanotechnology is expected to address these limitations and thus improve the therapeutic outcomes. Herein, we summarized important recent advances in the design of ALA-based prodrugs using nanotechnology to improve the efficacy of PDT. The potential limitations and future perspectives of ALA-based nanomedicines are also briefly presented and discussed.https://www.frontiersin.org/articles/10.3389/fphar.2023.1137707/full5-aminolevulinic acidbiotransformationphotodynamic therapyprodrugnanotechnology
spellingShingle Liang Lou
Shizhe Zhou
Sijia Tan
Menghua Xiang
Wei Wang
Chuang Yuan
Chuang Yuan
Liqian Gao
Qicai Xiao
Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
Frontiers in Pharmacology
5-aminolevulinic acid
biotransformation
photodynamic therapy
prodrug
nanotechnology
title Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
title_full Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
title_fullStr Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
title_full_unstemmed Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
title_short Amplifying the efficacy of ALA-based prodrugs for photodynamic therapy using nanotechnology
title_sort amplifying the efficacy of ala based prodrugs for photodynamic therapy using nanotechnology
topic 5-aminolevulinic acid
biotransformation
photodynamic therapy
prodrug
nanotechnology
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1137707/full
work_keys_str_mv AT lianglou amplifyingtheefficacyofalabasedprodrugsforphotodynamictherapyusingnanotechnology
AT shizhezhou amplifyingtheefficacyofalabasedprodrugsforphotodynamictherapyusingnanotechnology
AT sijiatan amplifyingtheefficacyofalabasedprodrugsforphotodynamictherapyusingnanotechnology
AT menghuaxiang amplifyingtheefficacyofalabasedprodrugsforphotodynamictherapyusingnanotechnology
AT weiwang amplifyingtheefficacyofalabasedprodrugsforphotodynamictherapyusingnanotechnology
AT chuangyuan amplifyingtheefficacyofalabasedprodrugsforphotodynamictherapyusingnanotechnology
AT chuangyuan amplifyingtheefficacyofalabasedprodrugsforphotodynamictherapyusingnanotechnology
AT liqiangao amplifyingtheefficacyofalabasedprodrugsforphotodynamictherapyusingnanotechnology
AT qicaixiao amplifyingtheefficacyofalabasedprodrugsforphotodynamictherapyusingnanotechnology